Health / Medical Topics

    SVN53-67/M57-KLH Peptide Vaccine

    A peptide vaccine containing a 15-mer peptide (DLAQMFFCFKELEGW), with C to M alteration at amino acid position 57, derived from the anti-apoptosis protein survivin, and conjugated with keyhole limpet hemocyanin (KLH), with potential immunopotentiating and antineoplastic activities. Upon subcutaneous administration of SVN53-67/M57-KLH peptide vaccine, this peptide is able to bind both HMC class I and II molecules and may activate the immune system to mount a cytotoxic T-lymphocyte (CTL) as well as a T-helper cell response against survivin-expressing cancer cells. This may result in decreased tumor cell proliferation and ultimately tumor cell death. Survivin, a member of the inhibitor of apoptosis (IAP) family, expressed during embryonic development while absent in most normal adult cells, is upregulated in a variety of human cancers; its expression in tumors is associated with a more aggressive phenotype, decreased survival, and increased resistance to chemotherapy. KLH may enhance immune recognition and may promote an enhanced response. As SVN53-67 is weakly immunogenic in humans, the M57 alteration may lead to greater affinity towards HLA-A*0201 and thus an enhanced antitumor immune response. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    A group of islands between the Arctic Ocean, Barents Sea, Greenland Sea, and Norwegian Sea, northeast of Iceland and north of…
    Simian virus 40. A virus that infects some types of monkeys. It may also infect humans, and was found in some polio…
    Human SUZ12 wild-type allele is located in the vicinity of 17q11.2 and is approximately 64 kb in length. This allele, which encodes…
    This gene plays a role in embryonic development and histone methylation.
    Human SUV420H2 is located in the vicinity of 19q13.42 and is approximately 8 kb in length. This allele, which encodes histone-lysine N-methyltransferase…
    This gene is involved in epigenetic control of gene expression.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact